Zebra Medical Vision set to bring AI to orthopedic care

Zebra Medical Vision has announced a new collaboration with DePuy Ireland Unlimited Company, agreeing to deploy cloud-based AI solutions focused on orthopedic care.

As a result of this new arrangement, DePuy Synthes companies will now have access Zebra Medical Vision’s AI algorithms, which “bring affordable pre-operative surgical planning to surgeons worldwide without the need for traditional MRI or CT-based imaging.” The technology will impact pre-operative, operative and post-operative patient care.

“We are thrilled to start this collaboration and have the opportunity to impact and improve orthopedic procedures and outcomes in areas including the knee, hip, shoulder, trauma, and spine care,” Eyal Gura, co-founder and CEO of Zebra Medical Vision, said in a prepared statement. “We share a common vision surrounding the impact we can have on patients’ lives through the use of AI, and we are happy to initiate such a meaningful strategic partnership, leveraging the tools and knowledge we have built around bone health AI in the last five years.” 

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.